National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors. Issue 1 (5th November 2021)

• Record Type: Journal Article
• Authors: Wallace, David; Cowling, Thomas E; Suddle, Abid; Gimson, Alex; Rowe, Ian; Callaghan, Chris; Sapisochin, Gonzalo; Ivanics, Tommy; Claasen, Marco; Mehta, Neil; Heaton, Nigel; van der Meulen, Jan; Walker, Kate
• Is Part Of: British journal of surgery. Volume 109:Issue 1(2022)
• Page Start: 79
• Page End: 88
• Publication Date: 2021-11-05
• Subjects: Surgery -- Periodicals; 617.005
• DOI: 10.1093/bjs/znab347
• Languages: English
• ISSNs: 0007-1323

Abstract

Abstract: Background: Despite high waiting list mortality rates, concern still exists on the appropriateness of using livers donated after circulatory death (DCD). We compared mortality and graft loss in recipients of livers donated after circulatory or brainstem death (DBD) across two successive time periods. Methods: Observational multinational data from the United Kingdom and Ireland were partitioned into two time periods (2008–2011 and 2012–2016). Cox regression methods were used to estimate hazard ratios (HRs) comparing the impact of periods on post-transplant mortality and graft failure. Results: A total of 1176 DCD recipients and 3749 DBD recipients were included. Three-year patient mortality rates decreased markedly from 19.6 per cent in time period 1 to 10.4 per cent in time period 2 (adjusted HR 0.43, 95 per cent c.i. 0.30 to 0.62; P < 0.001) for DCD recipients but only decreased from 12.8 to 11.3 per cent (adjusted HR 0.96, 95 per cent c.i. 0.78 to 1.19; P = 0.732) in DBD recipients ( P for interaction = 0.001). No time period-specific improvements in 3-year graft failure were observed for DCD (adjusted HR 0.80, 95% c.i. 0.61 to 1.05; P = 0.116) or DBD recipients (adjusted HR 0.95, 95% c.i. 0.79 to 1.14; P = 0.607). A slight increase in retransplantation rates occurred between time period 1 and 2 in those who received a DCD liver (from 7.3 to 11.8 per cent; P = 0.042), but there was no change in those receiving a DBD liver (from 4.9 to 4.5 per cent; P = 0.365). In time period 2, no difference in mortality rates between those receiving a DCD liver and those receiving a DBD liver was observed (adjusted HR 0.78, 95% c.i. 0.56 to 1.09; P = 0.142). Conclusion: Mortality rates more than halved in recipients of a DCD liver over a decade and eventually compared similarly to mortality rates in recipients of a DBD liver. Regions with high waiting list mortality may mitigate this by use of DCD livers. Abstract : Despite high waiting list mortality rates, international concern still exists about the efficacy of livers donated after circulatory death (DCD). However, between 2008 and 2016, mortality rates more than halved in the United Kingdom and Ireland in those who received a DCD liver and is now comparable to recipients of a liver donated following brainstem death (DBD). Countries with high waiting list mortality rates should consider increasing the use of DCD livers.